Catalyst Wire Dossier Catalyst Wire Dossier

Barzolvolimab

barzolvolimab · Celldex Therapeutics
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Barzolvolimab, covering 2026-01-30 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria [Phase 3]

See pricing